Familial hCG syndrome: production of variable, degraded or mutant forms of hCG

Area of Science:

• Endocrinology
• Reproductive Biology
• Biochemistry

Background:

• Familial human chorionic gonadotropin (hCG) syndrome is a rare genetic condition.
• It is characterized by the production of unique, degraded forms of hCG.
• Understanding these forms is crucial for accurate diagnosis and monitoring.

Purpose of the Study:

• To characterize the specific properties of degraded hCG forms in familial hCG syndrome.
• To report on 15 cases of this syndrome referred to the USA hCG Reference Service.
• To investigate the molecular basis of the observed hCG abnormalities.

Main Methods:

• Immunoassays (Immulite and Centaur) were used to quantify total hCG and hCG lacking the beta-subunit C-terminal peptide.
• Free beta-subunit levels were measured using a specific assay.
• Epitope and gel filtration studies were conducted.

Main Results:

• Familial hCG syndrome was confirmed by ectopic hCG production in family members.
• Serum hCG levels ranged from 1-216 mIU/mL and urine hCG from 1.5-527 mIU/mL.
• 48-100% of hCG molecules lacked the beta-subunit C-terminal peptide, with free beta-subunit comprising 52-79% of total hCG immunoreactivity.

Conclusions:

• The high proportion of hCG molecules missing the C-terminal peptide is a hallmark of this syndrome.
• Further studies suggest the C-terminal peptide may not be truly absent but unrecognized due to a mutant beta-subunit.
• This finding has implications for understanding hCG structure-function relationships and diagnostic assays.